recall
saveCipla USA, Inc. recall (Cls II)
December 17, 2025updated 5mo ago
community read0 votes
Cinacalcet Hydrochloride Tablets, 60 mg, 30 Tablets per bottle, Rx Only, Manufactured for: Cipla USA, Inc., 10 Independence Boulevard, Suite 300, Warren, NJ 07059. NDC: 69097-411-02 — Reason: CGMP Deviations: the presence of a nitrosamine impurity, N-nitroso-cinacalcet, above the acceptable daily intake (ADI) limits. — Status: Ongoing
view source ↗Data sources
last refreshed 32m ago
Found something off?
same company · ±60 days · 6
🐶 often sniffed alongside
top 8- tagRecall27 co-mentions · 16 sources
- companyCipla Ltd7 co-mentions · 5 sources
- druglanthanum carbonate6 co-mentions · 4 sources
- druglanreotide acetate6 co-mentions · 3 sources
- drugCINACALCET HYDROCHLORIDE6 co-mentions · 3 sources
- drugNILOTINIB4 co-mentions · 2 sources
- tagCRO/CDMO4 co-mentions · 2 sources
- companyInvaGen Pharmaceuticals Inc3 co-mentions · 2 sources
comments(0)
5-min edit window · permanent after that